Literature DB >> 11919640

Will public health survive QALYs?

James G Heller1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11919640

Source DB:  PubMed          Journal:  Can J Clin Pharmacol        ISSN： 1198-581X


× No keyword cloud information.
  2 in total

Review 1.  Socio-economic aspects of neuroimmunological diseases.

Authors:  Peter Rieckmann
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

2.  Cost-effectiveness of multiple sclerosis disease-modifying therapies: a systematic review of the literature.

Authors:  David Yamamoto; Jonathan D Campbell
Journal:  Autoimmune Dis       Date:  2012-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.